BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18782756)

  • 1. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
    Dugan AS; Maginnis MS; Jordan JA; Gasparovic ML; Manley K; Page R; Williams G; Porter E; O'Hara BA; Atwood WJ
    J Biol Chem; 2008 Nov; 283(45):31125-32. PubMed ID: 18782756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agnoprotein Is an Essential Egress Factor during BK Polyomavirus Infection.
    Panou MM; Prescott EL; Hurdiss DL; Swinscoe G; Hollinshead M; Caller LG; Morgan EL; Carlisle L; Müller M; Antoni M; Kealy D; Ranson NA; Crump CM; Macdonald A
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
    Xu C; Wang A; Marin M; Honnen W; Ramasamy S; Porter E; Subbian S; Pinter A; Melikyan GB; Lu W; Chang TL
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid.
    Zins SR; Nelson CD; Maginnis MS; Banerjee R; O'Hara BA; Atwood WJ
    J Virol; 2014 Jan; 88(2):948-60. PubMed ID: 24198413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor-1 alpha.
    Signorini L; Croci M; Boldorini R; Varella RB; Elia F; Carluccio S; Villani S; Bella R; Ferrante P; Delbue S
    J Cell Physiol; 2016 Jun; 231(6):1343-9. PubMed ID: 26529465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
    Wiens ME; Smith JG
    J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
    Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
    Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
    J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
    Valere K; Lu W; Chang TL
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of BK virus and human papillomavirus in human prostate cancer.
    Balis V; Sourvinos G; Soulitzis N; Giannikaki E; Sofras F; Spandidos DA
    Int J Biol Markers; 2007; 22(4):245-51. PubMed ID: 18161654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Structure of an Infectious Human Polyomavirus and Its Interactions with Cellular Receptors.
    Hurdiss DL; Frank M; Snowden JS; Macdonald A; Ranson NA
    Structure; 2018 Jun; 26(6):839-847.e3. PubMed ID: 29706532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cytoskeletal components in BK virus infectious entry.
    Eash S; Atwood WJ
    J Virol; 2005 Sep; 79(18):11734-41. PubMed ID: 16140751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of adenovirus neutralization by Human alpha-defensins.
    Smith JG; Nemerow GR
    Cell Host Microbe; 2008 Jan; 3(1):11-9. PubMed ID: 18191790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK Polyomavirus Hijacks Extracellular Vesicles for
    Handala L; Blanchard E; Raynal PI; Roingeard P; Morel V; Descamps V; Castelain S; Francois C; Duverlie G; Brochot E; Helle F
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on BK virus entry and intracellular trafficking.
    Dugan AS; Eash S; Atwood WJ
    Transpl Infect Dis; 2006 Jun; 8(2):62-7. PubMed ID: 16734628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.
    Rapista A; Ding J; Benito B; Lo YT; Neiditch MB; Lu W; Chang TL
    Retrovirology; 2011 Jun; 8():45. PubMed ID: 21672195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence.
    An P; Sáenz Robles MT; Duray AM; Cantalupo PG; Pipas JM
    PLoS Pathog; 2019 Jan; 15(1):e1007505. PubMed ID: 30620752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Human Renal-Derived Tubular Epithelial Cells Fail to Recognize and Suppress BK Virus Infection.
    de Kort H; Heutinck KM; Ruben JM; Ede V Silva A; Wolthers KC; Hamann J; Ten Berge IJM
    Transplantation; 2017 Aug; 101(8):1820-1829. PubMed ID: 27755502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.
    Mathew B; Nagaraj R
    Peptides; 2015 Sep; 71():128-40. PubMed ID: 26206286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth.
    Dugan AS; Gasparovic ML; Tsomaia N; Mierke DF; O'Hara BA; Manley K; Atwood WJ
    J Virol; 2007 Nov; 81(21):11798-808. PubMed ID: 17699578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.